ES2140356A1 - Natural revitalizer. - Google Patents

Natural revitalizer.

Info

Publication number
ES2140356A1
ES2140356A1 ES009801739A ES9801739A ES2140356A1 ES 2140356 A1 ES2140356 A1 ES 2140356A1 ES 009801739 A ES009801739 A ES 009801739A ES 9801739 A ES9801739 A ES 9801739A ES 2140356 A1 ES2140356 A1 ES 2140356A1
Authority
ES
Spain
Prior art keywords
weight
revitalizer
natural
percentage
active component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES009801739A
Other languages
Spanish (es)
Other versions
ES2140356B1 (en
Inventor
Saura Manuel Castro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to ES009801739A priority Critical patent/ES2140356B1/en
Publication of ES2140356A1 publication Critical patent/ES2140356A1/en
Application granted granted Critical
Publication of ES2140356B1 publication Critical patent/ES2140356B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Natural revitalizer. The natural revitalizer includes at least one active component which is characterized by the fact that said at least one active component is a mixture of rosemary in a percentage by weight between 8 and 68%, preferably 26.6% by weight, guarana in a percentage by weight between 12 and 72%, preferably 33.3% by weight, and eleutherococcus in a percentage by weight between 20 and 80%, preferably 40% by weight. It is a physioenergetic complement, especially against physical exhaustion, sexual impotence, changes in arterial pressure, various depressive conditions or stress problems in general.
ES009801739A 1998-08-12 1998-08-12 NATURAL REVITALIZING. Expired - Fee Related ES2140356B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES009801739A ES2140356B1 (en) 1998-08-12 1998-08-12 NATURAL REVITALIZING.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009801739A ES2140356B1 (en) 1998-08-12 1998-08-12 NATURAL REVITALIZING.

Publications (2)

Publication Number Publication Date
ES2140356A1 true ES2140356A1 (en) 2000-02-16
ES2140356B1 ES2140356B1 (en) 2000-09-16

Family

ID=8304887

Family Applications (1)

Application Number Title Priority Date Filing Date
ES009801739A Expired - Fee Related ES2140356B1 (en) 1998-08-12 1998-08-12 NATURAL REVITALIZING.

Country Status (1)

Country Link
ES (1) ES2140356B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1925313A1 (en) * 2006-11-24 2008-05-28 Nestec S.A. Prevention and treatment of disorders connected to impaired neurotransmission

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6049775A (en) * 1983-08-29 1985-03-19 Sanyuu Shoji Kk Production of nutrient food
US4973467A (en) * 1989-10-13 1990-11-27 Natrol, Inc. Dietary supplement for adults
FR2687548A1 (en) * 1992-02-20 1993-08-27 Bioes Laboratoires Novel low-calory dietetic composition
FR2712191A1 (en) * 1993-11-08 1995-05-19 Bioes Laboratoires Herbal antifatigue and slimming compsns.
GB2285578A (en) * 1993-12-22 1995-07-19 Leilani Lea Beverages containing added guaranine

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6049775A (en) * 1983-08-29 1985-03-19 Sanyuu Shoji Kk Production of nutrient food
US4973467A (en) * 1989-10-13 1990-11-27 Natrol, Inc. Dietary supplement for adults
FR2687548A1 (en) * 1992-02-20 1993-08-27 Bioes Laboratoires Novel low-calory dietetic composition
FR2712191A1 (en) * 1993-11-08 1995-05-19 Bioes Laboratoires Herbal antifatigue and slimming compsns.
GB2285578A (en) * 1993-12-22 1995-07-19 Leilani Lea Beverages containing added guaranine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN, PAJ CD-ROM, A21-24 (1976-1993) / 2, & JP 60049775 A (SANYUU SHOJI KK) *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1925313A1 (en) * 2006-11-24 2008-05-28 Nestec S.A. Prevention and treatment of disorders connected to impaired neurotransmission
WO2008062046A1 (en) * 2006-11-24 2008-05-29 Nestec S.A. Prevention and treatment of disorders connected to impaired neurotransmission
JP2010510293A (en) * 2006-11-24 2010-04-02 ネステク ソシエテ アノニム Prevention and treatment of disorders related to neurotransmission disorders
RU2455017C2 (en) * 2006-11-24 2012-07-10 Нестек С.А. Prevention and treatment of disorders associated with disturbed neurotransmission

Also Published As

Publication number Publication date
ES2140356B1 (en) 2000-09-16

Similar Documents

Publication Publication Date Title
BG101966A (en) Application of 1l-agonist for the treatment of lack of urine retention
NZ324603A (en) Treatment of the CNS effects of HIV with VX-478, alone or in combination with AZT or 3TC
HK1079978A1 (en) Methods of treating or preventing autoimmune diseases with 2,4- pyrimidinediamine compounds
BG101851A (en) Hepatitis vaccine
UA39099C2 (en) Cyclic nitrogen-containing derivatives, mixture of isomers thereof or separate isomers or salts thereof
DE59410116D1 (en) COMBINATION PRODUCT FOR CONTRACTION CONTAINING PROGESTERONANTAGONISTS AND STAGE
SG145698A1 (en) Methods of treating or preventing autoimmune diseases with 2,4- pyrimidinediamine compounds
BR0206644A (en) Sterol absorption inhibitor (s) combinations with cardiovascular agent (s) for the treatment of vascular conditions
MX9705235A (en) Substituted oxazolidine calpain and/or cathepsin b inhibitors.
HUP0101594A2 (en) Use of parathormone for increasing bone toughness and stiffness and reducing fractures
EP1478322A4 (en) Beta-2'-OR 3'-HALONUCLEOSIDES
BR9902837A (en) Synchronous body with pressure piece or integrated insert
DE59911542D1 (en) Mixtures containing thermoplastic polyurethane
TW200500361A (en) Compositions, combinations, and methods for treating cardiovascular conditions and other associated conditions
MY120524A (en) Part or jig for gas carburizing furnace
FI20012460A (en) Rörgrensstycke
GB9725749D0 (en) Compound
GB2380939B (en) Treatment or prevention of auto-immune diseases
BG101232A (en) Bactericides
ES1010119U (en) Double mouth clip.
ES2140356A1 (en) Natural revitalizer.
TWI268294B (en) High-uniformity spandex and process for making spandex
EP0318233A3 (en) Improvements in or relating to serotonin and norepinephrine uptake inhibitors
BG103789A (en) Fungicidal compositions
MY120530A (en) Combination preparation for use in dementia

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20000216

Kind code of ref document: A1

Effective date: 20000216

FD1A Patent lapsed

Effective date: 20050813